داروسازیزهراوی
دزهراوی | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 5,280 2.92
Close Price: 5,280
Financial Ratios
AGM
Interim
2026/06/20 Fiscal Year 2026/03/2012 Month | 2025/05/03 Fiscal Year 2025/03/2012 Month | 2024/07/09 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Net Profit to Sales | 21.04 | 5.4 | 0.06 | |
Gross Profit to Sales | 26.6 | 8.08 | 6.73 | |
Operating Margin | 29.91 | 17.58 | 19.76 | |
Gross Profit to Sales | 41.15 | 34.69 | 38.77 | |
Net Profit to Gross Profit | 51.13 | 15.56 | 0.14 | |
Return on Assets (ROA) | 12.68 | 2.75 | 0.02 | |
Return on Capital (%) | 30.08 | 15.38 | 0.11 | |
Return on Equity (ROE) | 23.02 | 4.54 | 0.03 | |
Working Capital Return | 74.77 | 36.22 | 0.34 | |
Fixed Asset Return | 31.06 | 4.84 | 0.03 | |
Loan Benefit Assessment | 1.82 | 1.65 | 1.63 | |
Current Ratio | 1.42 | 1.23 | 1.19 | |
Quick Ratio | 1.2 | 0.98 | 0.92 | |
Liquidity Ratio | 0.07 | 0.04 | 0.04 | |
Net Working Capital | 4,277,421 | 1,360,645 | 1,004,252 | |
Current Assets Ratio | 0.57 | 0.41 | 0.37 | |
Inventory Turnover | 75.63 | 90.09 | 111.52 | |
Receivables Collection Period | 266.74 | 208.28 | 252.33 | |
Inventory to Working Capital | 0.52 | 1.1 | 1.44 | |
Working Capital Turnover | 3.55 | 6.71 | 6.19 | |
Fixed Asset Turnover | 1.48 | 0.9 | 0.6 | |
Total Asset Turnover | 0.6 | 0.51 | 0.37 | |
Debt Ratio | 0.45 | 0.4 | 0.39 | |
Debt to Equity | 0.82 | 0.65 | 0.63 | |
Long-Term Debt to Equity | 0.02 | 0.01 | 0.04 | |
Current Debt to Equity | 0.74 | 0.55 | 0.51 | |
Equity Ratio | 55.07 | 60.48 | 61.18 | |
Debt Coverage Ratio | 38.44 | 64.67 | 26.03 |
